(2 H, m, CH2), 3.34 (6 H, s, OMe), 3.64 (2 H, m, OCH); δC 21.3,
29.7, 56.8, 86.3.
2,3-O-isopropylidene-β--xylopyranoside 2413 via the corre-
1
sponding xanthate, mp 95–97 ЊC (lit.,35 93–97 ЊC). The H
NMR spectrum of 27 was identical to that described in the
literature;35 δC 26.5, 26.7, 56.5, 62.9, 64.2, 76.2, 79.2, 103.4,
110.3.
cis-1,2-Dimethoxycyclopentane 5-cis. This was prepared in
60% yield from the cis-diol by the method used for the trans-
isomer; bp 70–72 ЊC/42 mmHg; δH 1.75 (6 H, m, CH2), 3.38
(6 H, s, OMe), 3.66 (2 H, m, OCH); δC 19.0, 27.2, 57.1, 82.0
(Found: C, 64.4; H, 10.9. C7H14O2 requires C, 64.6; H, 10.8%).
Methyl
4-deoxy-2,3-O-isopropylidene-ꢁ-D-erythro-pento-
pyranoside 28. A 1 : 3 mixture of methyl 2,3-O-isopropylidene-
β--ribofuranoside 30 and methyl 3,4-O-isopropylidene-β--
ribofuranoside 31 was prepared according to the published
procedure.14 All attempts to isolate pure 30 by flash chroma-
tography were unsuccessful and a mixture of the two com-
pounds was converted to a mixture of the corresponding
xanthates. Sodium hydride (60% in mineral oil; 0.55 g, 13.8
mmol) was added with stirring to a chromatographically
enriched 45 : 55 mixture of 30 and 31 (2.57 g, 12.6 mmol) and
imidazole (10 mg) in dry tetrahydrofuran (50 cm3) under argon
at 0 ЊC. The mixture was allowed to warm to room temperature
and was stirred until liberation of hydrogen ceased (ca. 25 min).
Carbon disulfide (2.51 g, 33 mmol) was added in one portion
and the mixture was stirred for a further 30 min. Iodomethane
(2.84 g, 20 mmol) was added dropwise and the mixture was then
stirred at room temperature for 1 h. The reaction mixture was
quenched with water (60 cm3), the organic layer was separated,
and the solvent was removed by rotary evaporation. The
aqueous phase was extracted with diethyl ether (3 × 15 cm3)
and the combined extracts were added to the residue from
the organic layer. The ethereal solution was washed with
saturated brine (20 cm3) and dried. The solvent was removed
by rotary evaporation and the residue was purified by flash
chromatography using petroleum spirit followed by petroleum
spirit–diethyl ether (10 : 1 then 5 : 1 v/v) as eluent. The xanthate
32 (1.48 g, 89% based on 30) was isolated from the earlier frac-
tions as a pale yellow oil; δH 1.37 (3 H, s, Me), 1.57 (3 H, s, Me),
2.59 (3 H, s, SMe), 3.45 (3 H, s, OMe), 3.85 (1 H, dd, J 11.0
and 8.1, HA-5), 3.95 (1 H, dd, J 11.0 and 5.0, HB-5), 4.11 (1 H,
dd, J 6.3 and 3.2, H-2), 4.60 (1 H, d, J 3.2, H-1), 4.63 (1 H, dd,
J 6.3 and 4.0, H-3), 6.06 (1 H, ddd, J 8.1, 5.0 and 4.0, H-4);
δC 25.5, 26.8, 56.2, 58.9, 67.9, 71.2, 74.0, 75.5, 100.6, 110.8,
215.9.
Isosorbide dimethyl ether 7. This was used as received from
Aldrich. Isomannide dimethyl ether 8 was prepared by methyl-
ation of isomannide with dimethyl sulfate in the presence of
potassium hydroxide, as described in the literature.30
endo,endo-cis-Bicyclo[3.3.0]octane-2,6-diol. This was pre-
pared according to the published method,8b bp 110–113 ЊC/0.02
mmHg (lit.,8b 130–144 ЊC/2.7 mmHg). The corresponding di-
methyl ether 118a was prepared from the diol by methylation
with dimethyl sulfate as described for isomannide dimethyl
ether,30 bp 45 ЊC/0.05 mmHg or 100–102 ЊC/15 mmHg; δH 1.40
(4 H, m, CH2), 1.80 (4 H, m, CH2), 2.55 (2 H, m, CH2), 3.29
(6 H, s, OMe), 3.72 (2 H, m, OCH); δC 20.4, 31.0, 43.0, 57.2,
84.4.
1,2:5,6-Di-O-isopropylidene-3-O-methyl-ꢀ-D-glucofuranoside
13. This was prepared according to the literature procedure;9
δH 1.32 (3 H, s, Me), 1.36 (3 H, s, Me), 1.43 (3 H, s, Me), 1.50
(3 H, s, Me), 3.45 (3 H, s, OMe), 3.77 (1 H, d, J 3.0, H-3), 4.01
(1 H, dd, J 8.6 and 5.4, HA-6), 4.08 (1 H, dd, J 8.6 and 4.5,
HB-6), 4.11 (1 H, dd, J 7.9 and 3.0, H-4), 4.30 (1 H, d[t], J 7.9
and 5.0, H-5), 4.56 (1 H, d, J 3.8, H-2), 5.86 (1 H, d, J 3.8, H-1);
δC 25.4, 26.2, 26.8, 26.9, 58.2, 67.2, 72.3, 81.0, 81.8, 83.6, 105.1,
109.0, 111.7.
3-Deoxy-1,2:5,6-di-O-isopropylidene-ꢀ-D-ribo-hexofuranose
15.31 This was prepared by reduction with triphenylsilane of the
xanthate derived from diacetone -glucose,10,32 bp 80–82 ЊC/0.5
mmHg (lit.,31 72–73 ЊC/0.2 mmHg); δH 1.32 (3 H, s, Me), 1.35
(3 H, s, Me), 1.42 (3 H, s, Me), 1.51 (3 H, s, Me), 1.77 (1 H, m,
HA-3), 2.18 (1 H, dd, J 13.7 and 4.1, HB-3), 4.13 (4 H, m, H-4,
-5 and -6), 4.75 (1 H, t, J 4.1), 5.82 (1 H, d, J 3.7, H-1); δC 25.1,
26.1, 26.4, 26.8, 35.2, 67.2, 76.7, 78.6, 80.4, 105.6, 109.6, 111.3.
The xanthate 32 (294 mg, 1.0 mmol) was treated with tri-
phenylsilane (310 mg, 1.2 mmol) and di-tert-butyl hyponitrite36
(8.4 mg, 5 mol%) in 1,4-dioxane (2 cm3) at 60 ЊC as described
previously10,32 to give 28 (155 mg, 82%) [α]2D0 Ϫ106.1 (c 3.8,
CHCl3); δH 1.36 (3 H, s, Me), 1.52 (3 H, s, Me), 1.89 (1 H, d[q],
J 14.6 and 4.0, HA-4), 2.01 (1 H, dd[t], J 14.9, 9.8 and 4.9,
HB-4), 3.46 (3 H, s, OMe), 3.66 (1 H, ddd, J 11.5, 9.8 and 3.7,
HA-5), 3.77 (1 H, d[t], J 11.5 and 4.7, HB-5), 3.86 (1 H, [t], J 5.1,
H-2), 4.38 (1 H, [q], J 4.8 H-3), 4.46 (1 H, d, J 4.7, H-1); δC 25.9,
27.3, 27.9, 56.2, 58.9, 71.5, 74.7, 101.8, 109.0 (Found: C, 57.2;
H, 8.7. C9H16O4 requires C, 57.4; H, 8.6%).
Methyl
2,3:5,6-di-O-isopropylidene-ꢀ-D-mannofuranoside
17.9,12 This was prepared according to the literature procedure;
δH 1.32 (3 H, s, Me), 1.38 (3 H, s, Me), 1.45 (3 H, s, Me), 1.46
(3 H, s, Me), 3.31 (3 H, s, OMe), 3.90 (1 H, dd, J 7.7 and 3.6,
H-4), 4.04 (1 H, dd, J 8.7 and 4.4, HA-6), 4.11 (1 H, dd, J 8.7
and 6.3, HB-6), 4.40 (1 H, ddd, J 7.7, 6.3 and 4.4, H-5), 4.56
(1 H, d, J, 5.9, H-2), 4.76 (1 H, dd, J 5.9 and 3.6, H-3), 4.87
(1 H, s, H-1); δC 24.6, 25.2, 25.9, 26.9, 54.6, 67.0, 73.2, 79.5,
80.3, 85.0, 107.4, 109.2, 112.6.
Compound 28 was also prepared by reduction of the xan-
thate 32 (2.94 g, 10.0 mmol) with tributyltin hydride to give
28 (1.77 g, 94%), bp 48–50 ЊC/0.05 mmHg.
trans- and cis-Acetonides 21 and 22. These were prepared
from trans- and cis-cyclohexane-1,2-diol, respectively, following
the published procedure.33
trans-2,2-Dimethyl-4,5-diphenyl-1,3-dioxolane 3637b,c and the
cis-isomer 37.37a These were prepared from the corresponding
diols as described in the literature.
Methyl 2,3-O-isopropylidene-4-O-methyl-ꢁ-D-xylopyranoside
25. This was prepared from 2413 by methylation with iodo-
methane, as described above for the preparation of 5,34 bp 70–
72 ЊC/0.05 mmHg; [α]2D0 Ϫ32.9 (c 0.85, CHCl3); δH 1.44 (3 H, s,
Me), 1.45 (3 H, s, Me), 3.28 (1 H, dd, J 12.0 and 7.4, HA-5), 3.33
(1 H, dd J 9.3 and 7.4, H-2), 3.47 (3 H, s, OMe), 3.52 (3 H, s,
OMe), 3.56 (1 H, dd, J 8.7 and 6.3, H-3), 3.50 (1 H, m, H-4),
4.10 (1 H, dd, J 12.0 and 4.7, HB-5), 4.53 (1 H, d, J 7.4, H-1);
δC 26.6, 26.8, 56.4, 57.8, 65.2, 76.7, 77.9, 80.2, 102.6, 111.7
(Found: C, 55.1; H, 8.2. C10H18O5 requires C, 55.0; H, 8.3%).
(4R,5S)-2,2-Dimethyl-4,5-diphenyl-N-valeryloxazolidine 38.
A mixture of (1S,2R)-2-amino-1,2-diphenylethanol (2.13 g,
10.0 mmol), aluminium powder (1.20 g, 44.4 mmol) and a
catalytic amount of acetyl chloride (20 mm3) in a mixture of
dry acetone (10 cm3) and dry dichloromethane (20 cm3) was
stirred under argon for 20 h at room temperature.38 Excess of
aluminium powder was removed by filtration and washed with
dichloromethane. The solvent was removed from the filtrate
by evaporation to give the essentially pure oxazolidine 42 as a
viscous oil (2.40 g, 95%), which was partially hydrolysed during
chromatography on silica gel; δH 1.58 (3 H, s, Me), 1.81 (3 H, s,
Methyl
4-deoxy-2,3-O-isopropylidene-ꢀ-L-threo-pento-
pyranoside 27.35 This was prepared by deoxygenation of methyl
2458
J. Chem. Soc., Perkin Trans. 1, 2001, 2452–2461